- Home
- EDBL vs BDRX Comparison
EDBL vs BDRX Comparison
Compare EDBL & BDRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EDBL
- BDRX
- Stock Information
- Founded
- EDBL 2020
- BDRX 2000
- Country
- EDBL United States
- BDRX United Kingdom
- Employees
- EDBL N/A
- BDRX N/A
- Industry
- EDBL Farming/Seeds/Milling
- BDRX Biotechnology: Pharmaceutical Preparations
- Sector
- EDBL Consumer Staples
- BDRX Health Care
- Exchange
- EDBL Nasdaq
- BDRX Nasdaq
- Market Cap
- EDBL 2.7M
- BDRX 3.5M
- IPO Year
- EDBL 2022
- BDRX N/A
- Fundamental
- Price
- EDBL $2.26
- BDRX $1.41
- Analyst Decision
- EDBL
- BDRX
- Analyst Count
- EDBL 0
- BDRX 0
- Target Price
- EDBL N/A
- BDRX N/A
- AVG Volume (30 Days)
- EDBL 73.0K
- BDRX 316.2K
- Earning Date
- EDBL 05-15-2025
- BDRX 05-16-2025
- Dividend Yield
- EDBL N/A
- BDRX N/A
- EPS Growth
- EDBL N/A
- BDRX N/A
- EPS
- EDBL N/A
- BDRX N/A
- Revenue
- EDBL $13,857,000.00
- BDRX N/A
- Revenue This Year
- EDBL $29.56
- BDRX N/A
- Revenue Next Year
- EDBL $20.00
- BDRX N/A
- P/E Ratio
- EDBL N/A
- BDRX N/A
- Revenue Growth
- EDBL N/A
- BDRX N/A
- 52 Week Low
- EDBL $1.82
- BDRX $1.14
- 52 Week High
- EDBL $230.00
- BDRX $74.00
- Technical
- Relative Strength Index (RSI)
- EDBL 52.38
- BDRX 41.59
- Support Level
- EDBL $1.87
- BDRX $1.28
- Resistance Level
- EDBL $2.40
- BDRX $1.50
- Average True Range (ATR)
- EDBL 0.15
- BDRX 0.11
- MACD
- EDBL 0.10
- BDRX 0.03
- Stochastic Oscillator
- EDBL 76.75
- BDRX 41.46
About EDBL Edible Garden AG Incorporated
Edible Garden AG Inc is a next-generation controlled environment agriculture farming company. It uses traditional agricultural growing techniques together with technology to grow fresh, organic food, sustainably and safely while improving traceability. The company uses the controlled environment of traditional greenhouse structures, such as glass greenhouses together with hydroponic and vertical greenhouses to sustainably grow organic herbs and lettuces.
About BDRX Biodexa Pharmaceuticals plc
Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasive bladder cancer (NMIBC), type 1 diabetes (T1D), and rare or orphan brain cancers.